FDA approval likely in April + US$ 10million milestone payment on market launch of Bronchitol , and we can expect $30-50 million in upfront payment for the LOXL drug ...If stock goes under 20c then it will be a great buying opp
Ann: Boehringer discontinues development of BI 1467335 for NASH, page-11
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.29M | |||
| Open | High | Low | Value | Volume |
| 3.2¢ | 3.2¢ | 3.2¢ | $30.50K | 953.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1747120 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 850000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |